VIVO™ Accuracy Study
Status: | Completed |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 11/17/2018 |
Start Date: | January 29, 2018 |
End Date: | November 1, 2018 |
A multi-center study designed to assess the accuracy of VIVO™ in determining the location of
a PVC/VT foci in comparison to an electroanatomical mapping system.
a PVC/VT foci in comparison to an electroanatomical mapping system.
The VIVO accuracy study will assess the accuracy of locating a PVC/VT foci by pacing known
anatomical locations and comparing the VIVO outcome to that of the Carto system
(Biosense-Webster).
anatomical locations and comparing the VIVO outcome to that of the Carto system
(Biosense-Webster).
Inclusion Criteria:
- Subjects who are at least 18 years or older
- Subjects who are scheduled for PVC/VT ablation procedure with structurally normal
hearts and less than 10% scar.
- Subjects who have signed an IRB/EC approved Informed Consent Form and applicable
subject privacy protection authorization per local law
- Subjects will be selected without regard to gender or age (unless precluded by local
regulatory requirements)
Exclusion Criteria:
- Subjects who are contraindicated for CT or MRI (must be able to get one)
- Subject whose MRI or CT scan does not comply with the requirements of this protocol
- Subjects who are contraindicated for an electrophysiology procedure and/or
fluoroscopy:
- INR > 3
- Active infection
- Pregnancy: Females of childbearing potential with a positive pregnancy test.
- Existing mechanical heart valve
We found this trial at
3
sites
University of Iowa With just over 30,000 students, the University of Iowa is one of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials